xixiwu
2021-06-04
[微笑]
@美股研究社:
美银:维持辉瑞“中性”评级,称公司的长期增长存在不确定性
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":116648906,"tweetId":"116648906","gmtCreate":1622798876805,"gmtModify":1622798876805,"author":{"id":3549952593571030,"authorId":3549952593571030,"authorIdStr":"3549952593571030","name":"xixiwu","avatar":"https://static.tigerbbs.com/9318bd8e9f4ff41619127a7bbfe19560","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n[微笑]</body></html>","htmlText":"<html><head></head><body>\n[微笑]</body></html>","text":"[微笑]","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/116648906","repostId":116948009,"repostType":1,"repost":{"magic":2,"id":116948009,"tweetId":"116948009","gmtCreate":1622771537901,"gmtModify":1622773865611,"author":{"id":3503452965237041,"authorId":3503452965237041,"authorIdStr":"3503452965237041","name":"美股研究社","avatar":"https://static.tigerbbs.com/a239c7906133df1f3817d0746a8a0ba1","vip":6,"userType":6,"introduction":"玩赚美股最好的资讯平台,你想要的美股行情、热点都在这里!","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/137719e6e1c02ef693e0f098fd37ac49","width":"688","height":"458"}],"coverImages":[{"img":"https://static.tigerbbs.com/137719e6e1c02ef693e0f098fd37ac49","width":"998","height":"664"}],"title":"美银:维持辉瑞“中性”评级,称公司的长期增长存在不确定性","extraTitle":"","html":"<html><head></head><body><p>美股研究社消息,智通财经APP获悉,以美国银行Geoff Meacham为首的分析师们表示,尽管<a target=\"_blank\" href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$</a> 在推广新冠疫苗方面发挥了巨大作用,但其超过三分之一的2020年主要产品将面临排他性损失(LOE),因此,对辉瑞维持“中性”评级,目标价40美元。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/137719e6e1c02ef693e0f098fd37ac49\" tg-width=\"688\" tg-height=\"458\"></p><p>分析师们认为,“推广新冠疫苗接种的最佳情况”应该会持续到今年下半年,但新冠疫苗业务的持久性存在不确定性。</p><p>分析师预计,在2025年末至2029年初,辉瑞超过35%的2020年主要产品将丧失专利保护,公司的长期增长存在不确定性,因此予“中性”评级。</p><p>然而,辉瑞似乎希望通过后续疫苗注射来维持与新冠疫苗相关的收入流。该公司首席执行官预测,人们在完全接种疫苗后的12个月内,仍需要额外注射疫苗。</p><p> 本文来源:美股研究社,转载请注明版权</p></body></html>","htmlText":"<html><head></head><body><p>美股研究社消息,智通财经APP获悉,以美国银行Geoff Meacham为首的分析师们表示,尽管<a target=\"_blank\" href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$</a> 在推广新冠疫苗方面发挥了巨大作用,但其超过三分之一的2020年主要产品将面临排他性损失(LOE),因此,对辉瑞维持“中性”评级,目标价40美元。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/137719e6e1c02ef693e0f098fd37ac49\" tg-width=\"688\" tg-height=\"458\"></p><p>分析师们认为,“推广新冠疫苗接种的最佳情况”应该会持续到今年下半年,但新冠疫苗业务的持久性存在不确定性。</p><p>分析师预计,在2025年末至2029年初,辉瑞超过35%的2020年主要产品将丧失专利保护,公司的长期增长存在不确定性,因此予“中性”评级。</p><p>然而,辉瑞似乎希望通过后续疫苗注射来维持与新冠疫苗相关的收入流。该公司首席执行官预测,人们在完全接种疫苗后的12个月内,仍需要额外注射疫苗。</p><p> 本文来源:美股研究社,转载请注明版权</p></body></html>","text":"美股研究社消息,智通财经APP获悉,以美国银行Geoff Meacham为首的分析师们表示,尽管$辉瑞(PFE)$ 在推广新冠疫苗方面发挥了巨大作用,但其超过三分之一的2020年主要产品将面临排他性损失(LOE),因此,对辉瑞维持“中性”评级,目标价40美元。 分析师们认为,“推广新冠疫苗接种的最佳情况”应该会持续到今年下半年,但新冠疫苗业务的持久性存在不确定性。 分析师预计,在2025年末至2029年初,辉瑞超过35%的2020年主要产品将丧失专利保护,公司的长期增长存在不确定性,因此予“中性”评级。 然而,辉瑞似乎希望通过后续疫苗注射来维持与新冠疫苗相关的收入流。该公司首席执行官预测,人们在完全接种疫苗后的12个月内,仍需要额外注射疫苗。 本文来源:美股研究社,转载请注明版权","highlighted":1,"essential":1,"paper":2,"link":"https://laohu8.com/post/116948009","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":597,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":748,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/116648906"}
精彩评论